Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival.
Ashirbani SahaMichael R HarowiczElizabeth Hope CainAllison H HallEun-Sil Shelley HwangJeffrey R MarksPaul Kelly MarcomMaciej A MazurowskiPublished in: Breast cancer research and treatment (2018)
Intra-tumor heterogeneity of ER receptor status may be a predictor of patient DRFS. Histopathologic data from multiple tissue samples may offer a view of tumor heterogeneity and assess recurrence risk.